January 2002
Royal Society of Medicine: Medicines;2002, p272
Reference Entry
This article presents information on gonadorelin, the hypothalamic hormone that acts on the pituitary gland to release the gonadotrophin hormones. It is therefore also known as luteinising hormone-releasing hormone. Gonadorelin is in fact the synthetic version of naturally occurring gonadotrophin-releasing hormone and is used for diagnostic purposes. It has been used for treatment, but now synthetic analogues of gonadorelin are instead used to treat endometriosis, infertility and breast and prostate cancer.


Related Articles

  • Better Results from GnRH Agonist vs. GnRH Antagonist Cycles.  // Fertility Weekly;1/29/2007, p5 

    The article cites a research conducted by Robert Medved and colleagues to compare the results of frozen-thawed blastocysts resulting from cycles using controlled ovarian stimulation with GnRH agonists versus GnRH antagonists. The researchers concluded that frozen-thawed blastocysts obtained from...

  • Involvement of nociceptin/orphanin FQ in release of hypothalamic GnRH mediated by ORL1 receptor in ovariectomized rats. Xiao-fei An; Hai-ping Chen; Shu-Ian Ma; Yi Feng; Jun-wei Had; Bo-ying Chen // Acta Pharmacologica Sinica;Sep2005, Vol. 26 Issue 9, p1039 

    To investigate effect of the nociceptin/orphanin FQ (OFQ) on hypothalamus gonadotropin-releasing hormone (GnRH) release in ovariectomized (OVX) rats. GnRH radioimmunoassay (RIA) was used to study the effect of OFQ on GnRH release in hypothalamus slices in vitro. Push-pull perfusion and...

  • Minimising menopausal side effects whilst treating endometriosis and fibroids. Simpson, Paul D; McLaren, James S; Rymer, Janice; Morris, Edward P // Post Reproductive Health;Mar2015, Vol. 21 Issue 1, p16 

    Medical management of endometriosis and fibroids involves manipulation of the hypothalamic–pituitary–gonadal axis to alter the balance of sex hormones thereby inhibiting disease progression and ameliorate symptoms. Unfortunately, resultant menopausal symptoms sometimes limit the...

  • GnRH agonists and antagonists in assisted reproduction: pregnancy rate. Engel, J. B.; Griesinger, G.; Schultze-Mosgau, A.; Felberbaum, R.; Diedrich, K. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jul2006, Vol. 13 Issue 1, p84 

    Although gonadotrophin-releasing hormone (GnRH) antagonists offer many advantages when used in ovarian stimulation. their popularity is lower than expected. GnRH protocols are suspected to yield lower pregnancy rates compared with the long agonist protocol. In the current study, subgroup...

  • Clinical relevance for the fact that GnRH antagonists do not down-regulate the GnRH receptor. Gordon, Keith; Stegmann, Barbara J. // Human Reproduction;Apr2013, Vol. 28 Issue 4, p1144 

    No abstract available.

  • THE EFFECT OF GnRH AGONIST VERSUS GnRH ANTAGONIST ON PREGNANCY RATE. Bastu, Ercan; Baysal, Bulent // Acta Endocrinologica (1841-0987);Apr-Jun2012, Vol. 8 Issue 2, p249 

    Context. Comparison of GnRH analogues and their impact on IVF treatment to improve pregnancy outcome. Objective. To compare the effects of GnRH agonists and GnRH antagonists on pregnancy rates. Design. A total of 458 women who had embryo transfers completed were analyzed retrospectively in a...

  • LRF.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1363 

    A definition of the acronym LRF which stands for luteinizing hormone releasing factor is presented.

  • GnRH antagonist yields better results than GnRH agonist short protocol in case of failure with GnRH long protocol. Haruki, A.; Migishima, F.; Ito, K.; Oku, Y.; Morimoto, Y. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;May2008 Supplement 2, Vol. 16 Issue S2, pS-19 

    Introduction: Gonadotrophin-releasing hormone (GnRH) antagonist has been applied in many centres, however the effectiveness of GnRH antagonist in ovarian stimulation is still controversial. In particular, it has not yet become evident whether GnRH antagonist or short GnRH agonist is more...

  • The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Seyide Soysal; Mehmet Emin Soysal; Suzan Ozer; Nýhat Gul; Tugba Gezgin // Human Reproduction;Jan2004, Vol. 19 Issue 1, p160 

    BACKGROUND: Among patients using GnRH analogues for endometriosis it has been postulated that peripheral and inflammation-induced in-situ aromatization of adrenal androgens are probably the main reasons for the high rates of failure during follow-up. We hypothesized that in cases with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics